Two Sigma Advisers LP Has $1.58 Million Position in Seer, Inc. (NASDAQ:SEER)

Two Sigma Advisers LP raised its position in Seer, Inc. (NASDAQ:SEER - Free Report) by 24.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 681,900 shares of the company's stock after acquiring an additional 132,800 shares during the quarter. Two Sigma Advisers LP owned approximately 1.16% of Seer worth $1,575,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in SEER. Y Intercept Hong Kong Ltd acquired a new stake in Seer in the 4th quarter worth about $36,000. Corient Private Wealth LLC increased its holdings in Seer by 66.0% in the 4th quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock valued at $77,000 after buying an additional 13,200 shares during the period. Schonfeld Strategic Advisors LLC bought a new position in Seer in the 4th quarter valued at about $103,000. OMERS ADMINISTRATION Corp acquired a new position in Seer during the 4th quarter worth approximately $114,000. Finally, Fuller & Thaler Asset Management Inc. acquired a new position in Seer during the 4th quarter worth approximately $179,000. Institutional investors and hedge funds own 75.20% of the company's stock.

Seer Price Performance

SEER stock traded up $0.03 during trading on Tuesday, reaching $2.17. 83,444 shares of the company were exchanged, compared to its average volume of 340,291. The company has a 50-day moving average of $1.95 and a two-hundred day moving average of $2.16. The company has a market capitalization of $127.45 million, a price-to-earnings ratio of -1.67 and a beta of 1.58. Seer, Inc. has a twelve month low of $1.56 and a twelve month high of $2.63.

Seer (NASDAQ:SEER - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share for the quarter, topping analysts' consensus estimates of ($0.37) by $0.03. The firm had revenue of $4.21 million for the quarter, compared to analyst estimates of $3.25 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. On average, analysts forecast that Seer, Inc. will post -1.42 EPS for the current year.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.